Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
JUBLPHARMA | BSE
-2.00
-0.42%
Healthcare
Drug Manufacturers-Specialty & Generic
30/09/2023
08/12/2023
473.10
477.40
491.95
469.35
Jubilant Pharmova Limited operates as an integrated pharmaceutical and life sciences company worldwide. It operates through three segments: Pharmaceuticals; Contract Research & Development Services; and Proprietary Novel Drugs. The Pharmaceuticals segment engages in the manufacturing and supply of allergy therapy products contract manufacturing of sterile injectables and non-sterile products active pharmaceutical ingredients and solid dosage formulations as well as sale of radiopharmaceuticals through a network of 48 radio pharmacies in the United States. The Contract Research & Development Services segment provides collaborative research services to pharmaceutical innovators. The Proprietary Novel Drugs segment develops therapies in the areas of oncology and auto-immune disorders. The company was formerly known as Jubilant Life Sciences Limited and changed its name to Jubilant Pharmova Limited in February 2021. Jubilant Pharmova Limited was incorporated in 1978 and is based in Noida India.
View LessPositive Momentum
Value Stock (Price to Book < 3)
Weakness based on declining price with high volume
High Current Volume and Negative 1-Day Return
Smallcap (300M - 2B USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
44.7%1 month
33.9%3 months
53.3%6 months
47.6%0
0
1.27
0.68
0.32
11.60
1.46
0
6.47B
74.98B
898.98M
1.16
8.64
1.06K
5.10
-0.89
0
0
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
83.35
Range1M
98.95
Range3M
172.65
Rel. volume
3.30
Price X volume
40.99M